CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr | ₹11,798 Cr |
What is the latest Appropriations of CIPLA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹22,179 Cr |
| Mar2024 | ₹18,471 Cr |
| Mar2023 | ₹16,054 Cr |
| Mar2022 | ₹13,523 Cr |
| Mar2021 | ₹11,798 Cr |
How is Appropriations of CIPLA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹22,179 Cr | 20.07 | |
| Mar2024 | ₹18,471 Cr | 15.06 | |
| Mar2023 | ₹16,054 Cr | 18.72 | |
| Mar2022 | ₹13,523 Cr | 14.62 | |
| Mar2021 | ₹11,798 Cr | - | |
Compare Appropriations of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,443.1 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
| MANKIND PHARMA | ₹85,977.0 Cr | -3.4% | -7.7% | -20.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.5% |
-8.1% |
-6.3% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses